
Trump's crackdown on pharmaceutical TV ads sparks widespread implications
The Trump administration's executive order aims to increase transparency in pharmaceutical TV advertising, potentially disrupting the industry and media revenue, with some experts suggesting legal challenges and a shift towards more honest drug marketing to improve public health awareness.





